Cartesian Therapeutics, Inc. - Common Stock (RNAC)
Seasonality Analysis
Cartesian Therapeutics, Inc. - Common Stock Annual Seasonality Statistics
Cartesian Therapeutics, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 6.92% | Moderate | |
| February | -1.17% | Weak | |
| March WORST | -10.12% | Weak | |
| April | -4.28% | Very Weak | |
| May BEST | 14.46% | Very Strong | |
| June | 3.03% | Weak | |
| July | -7.06% | Very Weak | |
| August | 3.23% | Moderate | |
| September | 3.58% | Strong | |
| October | 2.24% | Weak | |
| November | -4.72% | Weak | |
| December | -6.94% | Very Weak |
Cartesian Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern
Cartesian Therapeutics, Inc. - Common Stock Interactive Seasonality Chart
Cartesian Therapeutics, Inc. - Common Stock Pattern Scanner
Cartesian Therapeutics, Inc. - Common Stock Seasonal Historical Performance
About Cartesian Therapeutics, Inc. - Common Stock (RNAC) Seasonality
Cartesian Therapeutics, Inc. - Common Stock (RNAC) has been analyzed using 10 years of historical data to identify seasonal patterns. Classified under Stocks, Cartesian Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Cartesian Therapeutics, Inc. - Common Stock is historically May, with an average return of 14.46% and a win rate of 78%. Conversely, March tends to be the weakest month, averaging -10.12% return.
Looking at the full calendar year, Cartesian Therapeutics, Inc. - Common Stock has an average annual return of -0.83% with an overall monthly win rate of 48.1%. Out of 12 months, 6 typically show positive average returns.
The seasonal pattern for Cartesian Therapeutics, Inc. - Common Stock has a consistency score of 52.6 (Fair), based on 11 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Cartesian Therapeutics, Inc. - Common Stock Seasonality FAQ
What is the best month to buy Cartesian Therapeutics, Inc. - Common Stock (RNAC)?
Historically, May has been the best month for Cartesian Therapeutics, Inc. - Common Stock, with an average return of 14.46% and a win rate of 78%. However, past performance does not guarantee future results.
What is the worst month for Cartesian Therapeutics, Inc. - Common Stock (RNAC)?
Based on historical data, March has been the weakest month for Cartesian Therapeutics, Inc. - Common Stock, with an average return of -10.12%. This is a historical observation and does not guarantee future results.
How reliable is RNAC seasonality data?
The seasonality analysis for Cartesian Therapeutics, Inc. - Common Stock is based on 10 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Cartesian Therapeutics, Inc. - Common Stock seasonality in my trading?
Use Cartesian Therapeutics, Inc. - Common Stock (RNAC) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.